This inventor holds 4 USPTO granted patents. Top assignee: University of Florida Research Foundation Inc.. Active years: 1989-1992.
Location History:
- Stamford, CT (US) (1989)
- St. Louis, MO (US) (1990)
- Machester, MO (US) (1992)
- Manchester, MO (US) (1992)
Company Filing History:
Years Active: 1989-1992
Title: David C. Osborn: Innovator in Ocular Implants
Introduction
David C. Osborn is a notable inventor based in St. Louis, MO (US). He has made significant contributions to the field of ocular implants, holding a total of 4 patents. His work focuses on improving medical devices and instruments that interact with living tissue.
Latest Patents
Among his latest patents, Osborn has developed innovative methods for modifying ocular implant polymer surfaces. One of his notable patents is titled "Ocular implants and methods for their manufacture." This patent describes a method for modifying an ocular implant polymer surface through gamma-irradiation or electron beam irradiation induced polymerization of N-vinylpyrrolidone, 2-hydroxyethylmethacrylate, or a mixture thereof. Another significant patent is related to "Surface modified surgical instruments, devices, implants, contact lenses." This patent outlines an improved method for producing hydrophilic coatings or plastic surfaces of medical devices, which enhances their compatibility with living tissue.
Career Highlights
David C. Osborn is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research in ocular technology. His work has been instrumental in developing safer and more effective medical devices.
Collaborations
Osborn has collaborated with esteemed colleagues such as Jeffrey A. Larson and Eugene P. Goldberg. These partnerships have contributed to the success of his innovative projects.
Conclusion
David C. Osborn is a prominent figure in the field of ocular implants, with a focus on enhancing medical devices through innovative methods. His contributions have the potential to significantly impact the medical community and improve patient outcomes.
